News Release

Symptom-based dosing for neonatal opioid withdrawal

JAMA

Peer-Reviewed Publication

JAMA Network

About The Study: This randomized clinical trial found that symptom-based dosing decreased time to medical readiness for discharge compared with a scheduled opioid taper approach among infants with opioid withdrawal cared for with Eat, Sleep, Console.

Corresponding Author: To contact the corresponding author, Lori A. Devlin, DO, email lori.devlinphinney@louisville.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2026.5782)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: This study is being presented at the annual Pediatric Academic Societies meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.5782?guestAccessKey=216997b4-05d9-49a5-b39a-7c039273e7d2&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042526


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.